Kathrin Malejko

Case report: two cases of rhabdomyolysis following esketamine treatment.

Frontiers in Psychiatry 2024 René Zeiss, Melissa Schweizer, Bernhard J. Connemann et al. 3 citations

Major depressive disorder is a mental disorder affecting millions of people worldwide. A considerable proportion of patients demonstrate a lack of response to conventional treatment. With the recent introduction of esketamine, a new treatment option has been approved for treatment-resistant depression. Although the medication is efficacious in a substantial portion of cases, rare, but possibly...